QCTB Publications

  1. Torchia J, et al. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. Cancer Cell. 2016 Dec 12; 30(6): 891-908. doi: 10.1016/j.ccell.2016.11.003. PubMed PMID: 27960086 http://www.sciencedirect.com/science/article/pii/S1535610816305098
  1. Nikbakht H, et al. Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma. Nat Commun. 2016 Apr 6; 7: 11185. doi: 10.1038/ncomms11185. PubMed PMID: 27048880 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823825/
  1. Thompson EM, et al. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. Lancet Oncol. 2016 Apr; 17(4): 484-95. doi: 10.1016/S1470-2045(15)00581-1. PubMed PMID: 26976201 https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26976201/
  1. Sturm D, et al. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs. Cell. 2016 Feb 25; 164(5):1060-72. doi: 10.1016/j.cell.2016.01.015. PubMed PMID: 2691943 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139621/
  1. Morrissy AS, et al. Divergent clonal selection dominates medulloblastoma at recurrence. Nature. 2016 Jan 21; 529(7586):351-7. doi: 10.1038/nature16478. PubMed PMID: 26760213. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936195/